UC Davis bioengineer and neuroscientist receives NIH Director’s New Innovator Award
By Kimberly Cummings
Prestigious recognition provides $2.3 million in research funding
(SACRAMENTO)
Christina Kim, assistant professor in the UC Davis Department of Neurology and faculty member of the Center for Neuroscience, has been selected as a 2023 NIH Director’s New Innovator Award recipient. The award, announced last month, is part of the NIH Common Fund’s High-Risk, High-Reward Research program.
Christina Kim
The NIH Director’s New Innovator Award supports research from exceptionally creative, early career investigators who propose innovative, high-impact projects in the biomedical, behavioral or social sciences.
“Tina is an exceptional innovator, and we are so grateful to have her as faculty at the Center for Neuroscience at UC Davis,” said Kimberley McAllister, director of the center. McAllister is a professor of neurology in the UC Davis School of Medicine and neurobiology, physiology and behavior in the College of Biological Sciences. “Receiving the NIH Director’s New Innovator Award is a remarkable honor and well-deserved.”
The grant will provide the Kim Lab with $2.3 million in funding over five years. Kim’s project, “Activity-dependent probes for spatially-defined proteomics” aims to develop and test new technologies to capture the protein expression of neurons whose activity is linked to certain health conditions.
A loss or imbalance of specific proteins is thought to be associated with many brain disorders, such as, epilepsy, neuropsychiatric disease, Alzheimer’s disease and autism. Ultimately, these new technologies may uncover biomarkers that can be targeted in specific subpopulations of neurons to treat these conditions.
“Receiving the NIH Director’s New Innovator Award is an incredible honor, and I am grateful to my lab and colleagues at UC Davis for their support,” said Kim. “This award will allow us to engineer new approaches for brain-wide mapping of molecular structure and function. Our goal is to identify brain regions modulated by neurotherapeutic drugs and discover the specific molecules involved in mediating their therapeutic effects.”
Engineering molecular technologies to decode neural networks
Established in 2021, the Kim Lab develops molecular and optical approaches to study the function and molecular organization of neurons in the brain.
Kim’s research with an interdisciplinary team of neuroscientists and engineers employs synthetic biology, in vivo 2-p imaging and stimulation, and in-depth molecular characterization to deconstruct the neural building blocks required to regulate motivated behavior in mice.
“Our goal is to develop a new class of technologies that will enable exquisite detail of what molecules change during brain disease states,” Kim said. “We ultimately hope to understand how the molecular and functional properties of neurons can be manipulated in real time to alleviate symptoms of neuropsychiatric diseases, such as addiction and depression.”
